Microcaps key facts
- Developer of a microencapsulation technology intended to protect pharmaceutical agents in drugs or fragrances in cosmetic products.
- Microcaps’s last known valuation is $45.3M.
- It has raised $15.9M; the latest was Later Stage VC ($10.2M) in Jun 2024.
- Notable investors include MassChallenge, Venture Kick, Zürcher Kantonalbank, Venture (Switzerland), ETH Zürich Foundation — 10 tracked in total.
- Status: Privately Held (backing).
- ·Watch Microcaps: the Monday email on marks, rounds and moves
Microcaps funding rounds
No funding rounds for Microcaps are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Microcaps valuation
Microcaps's last known valuation is $45.3 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Microcaps investors
10 investors are on record for Microcaps, including MassChallenge, Venture Kick, Zürcher Kantonalbank and Venture (Switzerland).
About Microcaps
Developer of a microencapsulation technology intended to protect pharmaceutical agents in drugs or fragrances in cosmetic products. The company offers a method to create liquid oil core microcapsules with a natural alginate shell and increase controlled microencapsulation production compared to conventional processes via a step emulsification device, enabling clients to achieve higher throughput rates without quality loss.
- Sector
- Materials and Resources
- HQ
- Schlieren, Switzerland
- Founded
- 2018
- Employees
- 31
- Website
- microcaps.ch/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Microcaps’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.